1 study found for:    14767498 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
Conditions: Breast Cancer;   Leukemia;   Lymphoma;   Neuroblastoma;   Ovarian Cancer;   Sarcoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: filgrastim;   Drug: amifostine trihydrate;   Drug: cyclophosphamide;   Drug: melphalan;   Procedure: peripheral blood stem cell transplantation

Indicates status has not been verified in more than two years